Innovita Biological Technology Co. Ltd. A (688253) — Cash Flow Quality Index
Innovita Biological Technology Co. Ltd. A (688253) has a Cash Flow Quality Index of 1.34x as of December 2025. Operating cash flow of CN¥193.13 Million exceeds net income of CN¥144.47 Million, indicating high earnings quality where cash backs reported profits. Explore Innovita Biological Technology Co. Ltd. cash flow conversion to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Innovita Biological Technology Co. Ltd. A Cash Flow Quality Index (2020–2025)
Historical Cash Flow Quality Index for Innovita Biological Technology Co. Ltd. A across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Innovita Biological Technology Co. Ltd. investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Innovita Biological Technology Co. Ltd. A (2020–2025)
Year-by-year earnings quality comparison for Innovita Biological Technology Co. Ltd. A. For live market cap and the full company financial profile, see Innovita Biological Technology Co. Ltd. (688253) market capitalisation.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.34x | CN¥193.13 Million | CN¥144.47 Million | ▲ +7.5% |
| 2024 | 1.24x | CN¥305.46 Million | CN¥245.69 Million | ▼ -16.8% |
| 2023 | 1.49x | CN¥259.85 Million | CN¥173.95 Million | ▲ +78.0% |
| 2022 | 0.84x | CN¥126.43 Million | CN¥150.68 Million | ▼ -5.1% |
| 2021 | 0.88x | CN¥106.27 Million | CN¥120.25 Million | ▼ -21.4% |
| 2020 | 1.12x | CN¥639.82 Million | CN¥569.00 Million | — |